
### [MONDO:0016581](http://purl.obolibrary.org/obo/MONDO_0016581)
**Label:** conotruncal heart malformations

**Subclasses:** [MONDO:0015103](http://purl.obolibrary.org/obo/MONDO_0015103) (pulmonary valve agenesis-tetralogy of fallot-absence of ductus arteriosus syndrome), [MONDO:0018499](http://purl.obolibrary.org/obo/MONDO_0018499) (double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy), [MONDO:0016077](http://purl.obolibrary.org/obo/MONDO_0016077) (congenital aortopulmonary window), [MONDO:0008343](http://purl.obolibrary.org/obo/MONDO_0008343) (pulmonary atresia with ventricular septal defect), [MONDO:0018498](http://purl.obolibrary.org/obo/MONDO_0018498) (double outlet right ventricle with subaortic or doubly committed ventricular septal defect), [MONDO:0008542](http://purl.obolibrary.org/obo/MONDO_0008542) (tetralogy of fallot), [MONDO:0020386](http://purl.obolibrary.org/obo/MONDO_0020386) (double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis), [MONDO:0018089](http://purl.obolibrary.org/obo/MONDO_0018089) (double outlet right ventricle), [MONDO:0020387](http://purl.obolibrary.org/obo/MONDO_0020387) (double outlet right ventricle with subpulmonary ventricular septal defect), [MONDO:0020388](http://purl.obolibrary.org/obo/MONDO_0020388) (double outlet right ventricle with non-committed subpulmonary ventricular septal defect), [MONDO:0020389](http://purl.obolibrary.org/obo/MONDO_0020389) (pulmonary valve agenesis-ventricular septal defect-persistent ductus arteriosus syndrome), [MONDO:0018072](http://purl.obolibrary.org/obo/MONDO_0018072) (persistent truncus arteriosus), [MONDO:0020390](http://purl.obolibrary.org/obo/MONDO_0020390) (pulmonary artery coming from patent ductus arteriosus), [MONDO:0020391](http://purl.obolibrary.org/obo/MONDO_0020391) (pulmonary artery coming from the aorta), [MONDO:0018090](http://purl.obolibrary.org/obo/MONDO_0018090) (double outlet left ventricle (disease)), [MONDO:0020064](http://purl.obolibrary.org/obo/MONDO_0020064) (pulmonary valve agenesis), [MONDO:0015239](http://purl.obolibrary.org/obo/MONDO_0015239) (abnormal origin of the pulmonary artery), 

**Mapped go classes:** [GO:0060486](http://purl.obolibrary.org/obo/GO_0060486) (Clara cell differentiation), [GO:0070848](http://purl.obolibrary.org/obo/GO_0070848) (response to growth factor), [GO:0061576](http://purl.obolibrary.org/obo/GO_0061576) (acyl-CoA ceramide synthase complex), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0007493](http://purl.obolibrary.org/obo/GO_0007493) (endodermal cell fate determination), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0043587](http://purl.obolibrary.org/obo/GO_0043587) (tongue morphogenesis), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0003205](http://purl.obolibrary.org/obo/GO_0003205) (cardiac chamber development), [GO:0110024](http://purl.obolibrary.org/obo/GO_0110024) (positive regulation of cardiac muscle myoblast proliferation), [GO:0071492](http://purl.obolibrary.org/obo/GO_0071492) (cellular response to UV-A), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0070166](http://purl.obolibrary.org/obo/GO_0070166) (enamel mineralization), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0001708](http://purl.obolibrary.org/obo/GO_0001708) (cell fate specification), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0030148](http://purl.obolibrary.org/obo/GO_0030148) (sphingolipid biosynthetic process), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:1900145](http://purl.obolibrary.org/obo/GO_1900145) (regulation of nodal signaling pathway involved in determination of left/right asymmetry), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0003221](http://purl.obolibrary.org/obo/GO_0003221) (right ventricular cardiac muscle tissue morphogenesis), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0060117](http://purl.obolibrary.org/obo/GO_0060117) (auditory receptor cell development), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0051891](http://purl.obolibrary.org/obo/GO_0051891) (positive regulation of cardioblast differentiation), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0001162](http://purl.obolibrary.org/obo/GO_0001162) (RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0060023](http://purl.obolibrary.org/obo/GO_0060023) (soft palate development), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:2000020](http://purl.obolibrary.org/obo/GO_2000020) (positive regulation of male gonad development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:1904086](http://purl.obolibrary.org/obo/GO_1904086) (regulation of epiboly involved in gastrulation with mouth forming second), [GO:0044344](http://purl.obolibrary.org/obo/GO_0044344) (cellular response to fibroblast growth factor stimulus), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0021644](http://purl.obolibrary.org/obo/GO_0021644) (vagus nerve morphogenesis), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0060017](http://purl.obolibrary.org/obo/GO_0060017) (parathyroid gland development), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0071141](http://purl.obolibrary.org/obo/GO_0071141) (SMAD protein complex), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0034399](http://purl.obolibrary.org/obo/GO_0034399) (nuclear periphery), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:2000027](http://purl.obolibrary.org/obo/GO_2000027) (regulation of organ morphogenesis), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0003143](http://purl.obolibrary.org/obo/GO_0003143) (embryonic heart tube morphogenesis), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0032911](http://purl.obolibrary.org/obo/GO_0032911) (negative regulation of transforming growth factor beta1 production), [GO:0032912](http://purl.obolibrary.org/obo/GO_0032912) (negative regulation of transforming growth factor beta2 production), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0042471](http://purl.obolibrary.org/obo/GO_0042471) (ear morphogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0035987](http://purl.obolibrary.org/obo/GO_0035987) (endodermal cell differentiation), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0051974](http://purl.obolibrary.org/obo/GO_0051974) (negative regulation of telomerase activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:0042473](http://purl.obolibrary.org/obo/GO_0042473) (outer ear morphogenesis), [GO:0042474](http://purl.obolibrary.org/obo/GO_0042474) (middle ear morphogenesis), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0097152](http://purl.obolibrary.org/obo/GO_0097152) (mesenchymal cell apoptotic process), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:0036146](http://purl.obolibrary.org/obo/GO_0036146) (cellular response to mycotoxin), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:2000195](http://purl.obolibrary.org/obo/GO_2000195) (negative regulation of female gonad development), [GO:1901210](http://purl.obolibrary.org/obo/GO_1901210) (regulation of cardiac chamber formation), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:2001037](http://purl.obolibrary.org/obo/GO_2001037) (positive regulation of tongue muscle cell differentiation), [GO:2001054](http://purl.obolibrary.org/obo/GO_2001054) (negative regulation of mesenchymal cell apoptotic process), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0005112](http://purl.obolibrary.org/obo/GO_0005112) (Notch binding), [GO:0001302](http://purl.obolibrary.org/obo/GO_0001302) (replicative cell aging), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0070206](http://purl.obolibrary.org/obo/GO_0070206) (protein trimerization), [GO:0060872](http://purl.obolibrary.org/obo/GO_0060872) (semicircular canal development), [GO:0003181](http://purl.obolibrary.org/obo/GO_0003181) (atrioventricular valve morphogenesis), [GO:0050291](http://purl.obolibrary.org/obo/GO_0050291) (sphingosine N-acyltransferase activity), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0048644](http://purl.obolibrary.org/obo/GO_0048644) (muscle organ morphogenesis), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0060510](http://purl.obolibrary.org/obo/GO_0060510) (Type II pneumocyte differentiation), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0048538](http://purl.obolibrary.org/obo/GO_0048538) (thymus development), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0051145](http://purl.obolibrary.org/obo/GO_0051145) (smooth muscle cell differentiation), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0060536](http://purl.obolibrary.org/obo/GO_0060536) (cartilage morphogenesis), [GO:0060415](http://purl.obolibrary.org/obo/GO_0060415) (muscle tissue morphogenesis), [GO:0061626](http://purl.obolibrary.org/obo/GO_0061626) (pharyngeal arch artery morphogenesis), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0048666](http://purl.obolibrary.org/obo/GO_0048666) (neuron development), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0072513](http://purl.obolibrary.org/obo/GO_0072513) (positive regulation of secondary heart field cardioblast proliferation), [GO:0060045](http://purl.obolibrary.org/obo/GO_0060045) (positive regulation of cardiac muscle cell proliferation), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0001103](http://purl.obolibrary.org/obo/GO_0001103) (RNA polymerase II repressing transcription factor binding), [GO:0035239](http://purl.obolibrary.org/obo/GO_0035239) (tube morphogenesis), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0014898](http://purl.obolibrary.org/obo/GO_0014898) (cardiac muscle hypertrophy in response to stress), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0055008](http://purl.obolibrary.org/obo/GO_0055008) (cardiac muscle tissue morphogenesis), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0060037](http://purl.obolibrary.org/obo/GO_0060037) (pharyngeal system development), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0043282](http://purl.obolibrary.org/obo/GO_0043282) (pharyngeal muscle development), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0060982](http://purl.obolibrary.org/obo/GO_0060982) (coronary artery morphogenesis), [GO:0003192](http://purl.obolibrary.org/obo/GO_0003192) (mitral valve formation), [GO:0003195](http://purl.obolibrary.org/obo/GO_0003195) (tricuspid valve formation), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:0072721](http://purl.obolibrary.org/obo/GO_0072721) (cellular response to dithiothreitol), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060979](http://purl.obolibrary.org/obo/GO_0060979) (vasculogenesis involved in coronary vascular morphogenesis), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- Thing 56.03%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 51.02%
- [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration) 50.56%
- [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration) 50.56%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 44.16%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003783](http://purl.obolibrary.org/obo/GO_0003783) (obsolete barbed-end actin capping activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003782](http://purl.obolibrary.org/obo/GO_0003782) (obsolete F-actin capping activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003781](http://purl.obolibrary.org/obo/GO_0003781) (obsolete actin bundling activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003780](http://purl.obolibrary.org/obo/GO_0003780) (obsolete actin cross-linking activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003778](http://purl.obolibrary.org/obo/GO_0003778) (obsolete dynactin motor) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003776](http://purl.obolibrary.org/obo/GO_0003776) (obsolete muscle motor activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003775](http://purl.obolibrary.org/obo/GO_0003775) (obsolete axonemal motor activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003773](http://purl.obolibrary.org/obo/GO_0003773) (obsolete heat shock protein activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%
- [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration) and ([GO:0003772](http://purl.obolibrary.org/obo/GO_0003772) (obsolete co-chaperonin activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 41.95%


